Condition: Artificial Intelligence (AI) · Cardiac Implantable Electrical Devices · Conduction Disorder of the Heart · Sponsor: National Defense Medical Center, Taiwan
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
This description comes directly from the study's public registry record.
Chin Lin · +886-2-8792-3100 · xup6fup0629@gmail.com
Wen-Yu Lin · +886-2-87923311 · salmon.lin1019@gmail.com
Always discuss trial participation with your own doctor first.
| Tri-Service General Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07217236